Skip to content

Is End Tidal CO2 Level Elevation During Upper Endoscopy With CO2 Gas Insufflation Physiologically Significant

Is End Tidal CO2 Level Elevation During Upper Endoscopy With CO2 Gas Insufflation Physiologically Significant

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04541667
Acronym
ETCO2
Enrollment
200
Registered
2020-09-09
Start date
2019-11-18
Completion date
2022-05-31
Last updated
2023-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endoscopy

Keywords

upper endoscopy, endoscope, abdominal discomfort, insufflation, carbon dioxide

Brief summary

During the course of an endoscopic procedure, air has historically been used to inflate the lumen to provide adequate visualization and allow for the endoscope to advance as necessary. In many adult centers, carbon dioxide is used for insufflation for all procedures. Many pediatric centers have started using carbon dioxide for insufflation during endoscopy based on the adult studies. Few pediatric studies have been done. This study is designed to test whether carbon dioxide is associated with any negative, post-procedural, outcomes in pediatric patients.

Detailed description

Luminal inflation is essential for adequate visualization and endoscope advancement during endoscopy. Although air has previously been the standard gas used, CO2 is increasing preferred in adult endoscopy centers, due to reports of decreased post-procedural abdominal discomfort compared to air. Few published studies in children demonstrated decreased abdominal discomfort with use of CO2, but safety concerns for its use in pediatric endoscopy remain. This is a Double-blinded, prospective, randomized study of all pediatric patients undergoing procedures involving upper endoscopy in the Childrens Hospital & Medical Center. Randomization will be for patients undergoing upper endoscopy related procedures. Patients will be randomized 1:1 for air or CO2. Vital signs will be recorded before the procedure, throughout the procedure and after the procedure until fully awake. While in the procedure room, end-tidal CO2 level will be continuously recorded.

Interventions

OTHERAir

Air will be used for luminal inflation.

OTHERCarbon Dioxide

Carbon dioxide will be used for luminal inflation.

Sponsors

Children's Hospital and Medical Center, Omaha, Nebraska
CollaboratorOTHER
University of Nebraska
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Masking description

This is a double-blinded, prospective, randomized study

Intervention model description

Eligible study participants will be randomized 1:1 into two study arms; one receiving air and the other receiving carbon dioxide for luminal inflation.

Eligibility

Sex/Gender
ALL
Age
6 Months to 19 Years
Healthy volunteers
No

Inclusion criteria

* Children 6 months to 19 years old and * Undergoing upper endoscopy at Children's Hospital & Medical Center in Omaha, NE and * Parents or legal guardians consent to the study

Exclusion criteria

* Patients and legal guardians who decline participation in the study * Patients with chronic respiratory disease (defined as severe asthma, bronchopulmonary dysplasia and cystic fibrosis-related pulmonary disease) * Patients with cyanotic heart disease * Patients with an ASA status of ≥ 3. * Patients who are wards of the state or in foster care * Prisoners * Patients undergoing colonoscopy only procedures or procedures not related to upper endoscopy

Design outcomes

Primary

MeasureTime frameDescription
Number of Procedures With Elevated End-tidal CO2 LevelsMeasured from time of procedure start to time of procedure conclusion this lasts usually from 1-2.5 hours.Compare the peak end-tidal CO2 levels (\>/= 60 mmHg) observed during endoscopy in children managed with endotracheal intubation or laryngeal mask airway using CO2 versus air

Secondary

MeasureTime frameDescription
Number of Participants Reporting Abdominal PainThis will be assessed before and after the procedurePain rating scales using FLACC and VAS will be used to assess self reported pain before and after the procedure

Countries

United States

Participant flow

Pre-assignment details

1 participant who consented withdrew consent prior to randomization. Therefore, this patient did not undergo randomization

Participants by arm

ArmCount
Air for Luminal Inflation
Patients randomized into this arm will have luminal inflation using air. Air: Air will be used for luminal inflation.
98
Air for Luminal Inflation
Patients randomized into this arm will have luminal inflation using air. Air: Air will be used for luminal inflation.
98
Carbon Dioxide for Luminal Inflation
Patients randomized into this arm will have luminal inflation using carbon dioxide. Carbon Dioxide: Carbon dioxide will be used for luminal inflation.
102
Carbon Dioxide for Luminal Inflation
Patients randomized into this arm will have luminal inflation using carbon dioxide. Carbon Dioxide: Carbon dioxide will be used for luminal inflation.
102
Total400

Baseline characteristics

CharacteristicAir for Luminal InflationCarbon Dioxide for Luminal InflationTotal
Age, Continuous12 years12 years12 years
BMI z score0.23 units on a scale0.61 units on a scale0.23 units on a scale
Ethnicity (NIH/OMB)
Hispanic or Latino
6 Procedures6 Procedures12 Procedures
Ethnicity (NIH/OMB)
Not Hispanic or Latino
92 Procedures96 Procedures188 Procedures
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Procedures0 Procedures0 Procedures
Race (NIH/OMB)
American Indian or Alaska Native
0 Procedures0 Procedures0 Procedures
Race (NIH/OMB)
Asian
0 Procedures0 Procedures0 Procedures
Race (NIH/OMB)
Black or African American
1 Procedures0 Procedures1 Procedures
Race (NIH/OMB)
More than one race
6 Procedures10 Procedures16 Procedures
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Procedures0 Procedures0 Procedures
Race (NIH/OMB)
Unknown or Not Reported
7 Procedures8 Procedures15 Procedures
Race (NIH/OMB)
White
84 Procedures84 Procedures168 Procedures
Region of Enrollment
United States
98 participants102 participants200 participants
Sex: Female, Male
Female
58 Procedures56 Procedures114 Procedures
Sex: Female, Male
Male
40 Procedures46 Procedures86 Procedures

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 980 / 102
other
Total, other adverse events
5 / 985 / 102
serious
Total, serious adverse events
0 / 980 / 102

Outcome results

Primary

Number of Procedures With Elevated End-tidal CO2 Levels

Compare the peak end-tidal CO2 levels (\>/= 60 mmHg) observed during endoscopy in children managed with endotracheal intubation or laryngeal mask airway using CO2 versus air

Time frame: Measured from time of procedure start to time of procedure conclusion this lasts usually from 1-2.5 hours.

Population: Participants in this groups refers to procedures. Procedure count was used for analysis and not participant count

ArmMeasureValue (COUNT_OF_UNITS)
Air for Luminal InflationNumber of Procedures With Elevated End-tidal CO2 Levels8 Procedures
Carbon Dioxide for Luminal InflationNumber of Procedures With Elevated End-tidal CO2 Levels21 Procedures
Secondary

Number of Participants Reporting Abdominal Pain

Pain rating scales using FLACC and VAS will be used to assess self reported pain before and after the procedure

Time frame: This will be assessed before and after the procedure

Population: Participant procedures randomized into air or CO2 for endoscopic insufflation. Participants reporting abdominal pain after procedure. Higher numbers are worse

ArmMeasureValue (NUMBER)
Air for Luminal InflationNumber of Participants Reporting Abdominal Pain14 participants
Carbon Dioxide for Luminal InflationNumber of Participants Reporting Abdominal Pain15 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026